FI20030652A0 - Parannettu immunomääritys - Google Patents

Parannettu immunomääritys

Info

Publication number
FI20030652A0
FI20030652A0 FI20030652A FI20030652A FI20030652A0 FI 20030652 A0 FI20030652 A0 FI 20030652A0 FI 20030652 A FI20030652 A FI 20030652A FI 20030652 A FI20030652 A FI 20030652A FI 20030652 A0 FI20030652 A0 FI 20030652A0
Authority
FI
Finland
Prior art keywords
ctni
terminal part
directed
antibody
improved immune
Prior art date
Application number
FI20030652A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Susann Eriksson
Kim Pettersson
Original Assignee
Susann Eriksson
Kim Pettersson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Susann Eriksson, Kim Pettersson filed Critical Susann Eriksson
Priority to FI20030652A priority Critical patent/FI20030652A0/fi
Publication of FI20030652A0 publication Critical patent/FI20030652A0/fi
Priority to ES04076042T priority patent/ES2264079T3/es
Priority to EP04076042A priority patent/EP1473567B1/fr
Priority to AT04076042T priority patent/ATE333649T1/de
Priority to DE602004001533T priority patent/DE602004001533T2/de
Priority to US10/819,213 priority patent/US7348157B2/en
Priority to US11/979,977 priority patent/US7638292B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
FI20030652A 2003-04-30 2003-04-30 Parannettu immunomääritys FI20030652A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys
ES04076042T ES2264079T3 (es) 2003-04-30 2004-04-01 Inmunoensayo de troponina cardiaca i.
EP04076042A EP1473567B1 (fr) 2003-04-30 2004-04-01 Dosage immunologique de la troponine I cardiaque
AT04076042T ATE333649T1 (de) 2003-04-30 2004-04-01 Immunotestverfahren für herz-troponin i
DE602004001533T DE602004001533T2 (de) 2003-04-30 2004-04-01 Immunoassay von kardialem Troponin I
US10/819,213 US7348157B2 (en) 2003-04-30 2004-04-07 Immunoassay
US11/979,977 US7638292B2 (en) 2003-04-30 2007-11-13 Immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys

Publications (1)

Publication Number Publication Date
FI20030652A0 true FI20030652A0 (fi) 2003-04-30

Family

ID=8566047

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030652A FI20030652A0 (fi) 2003-04-30 2003-04-30 Parannettu immunomääritys

Country Status (6)

Country Link
US (2) US7348157B2 (fr)
EP (1) EP1473567B1 (fr)
AT (1) ATE333649T1 (fr)
DE (1) DE602004001533T2 (fr)
ES (1) ES2264079T3 (fr)
FI (1) FI20030652A0 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
ES2550004T3 (es) 2006-04-04 2015-11-03 Singulex, Inc. Sistema de alta sensibilidad y métodos de análisis de la troponina
CN103353531B (zh) * 2006-04-04 2019-03-08 神谷来克斯公司 用于肌钙蛋白分析的高灵敏系统和方法
AU2014200749B2 (en) * 2006-04-04 2016-04-14 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US9285362B2 (en) * 2006-10-18 2016-03-15 Axela, Inc. Measuring multiple analytes over a broad range of concentrations using optical diffraction
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
EP2097750A2 (fr) 2006-10-26 2009-09-09 Abbott Laboratories Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
EP2265950B1 (fr) 2008-03-05 2019-01-23 Axela Inc. Détection de biomarqueurs et complexes de biomarqueurs
US8450069B2 (en) 2009-06-08 2013-05-28 Singulex, Inc. Highly sensitive biomarker panels
CN102549429B (zh) * 2009-09-14 2015-08-19 皇家飞利浦电子股份有限公司 使用大颗粒标记的高灵敏性免疫测定
EP2480887B1 (fr) * 2009-09-23 2015-12-16 Koninklijke Philips N.V. Essai de liaison avec des agents de liaison de traceur marqués de façon magnétique multiples
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
US20110301053A1 (en) 2010-05-06 2011-12-08 Singulex, Inc. Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
US9834596B2 (en) 2012-07-03 2017-12-05 Washington University Antibodies to tau
CN103940986B (zh) * 2014-03-24 2015-10-21 安徽省煦棠医疗科技有限公司 肌钙蛋白i特定位点抗体制备及其检测试剂盒
TW202136296A (zh) 2014-06-27 2021-10-01 美商Ｃ２Ｎ醫療診斷有限責任公司 人類化抗-tau抗體
ES2792227T3 (es) 2014-09-26 2020-11-10 Somalogic Inc Predicción de evento de riesgo cardiovascular y usos de la misma
JP6651794B2 (ja) * 2015-11-05 2020-02-19 富士レビオ株式会社 心筋トロポニンｉ測定試薬及び方法
CN111018975B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018978B (zh) * 2018-10-10 2022-11-04 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018974B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018973B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018980B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018977B (zh) * 2018-10-10 2022-04-01 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的重组抗体
CN111018982B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018981B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN111018979B (zh) * 2018-10-10 2021-12-03 东莞市朋志生物科技有限公司 一种抗人心肌肌钙蛋白i的抗体及其应用
CN110836973A (zh) * 2019-09-09 2020-02-25 浙江博实生物科技有限公司 检测肌钙蛋白及复合物的双标记试剂盒及制备与检测方法
CN111308085B (zh) * 2019-12-30 2021-02-23 菲鹏生物股份有限公司 一种超敏心肌肌钙蛋白i检测方法和试剂盒
CN114384249A (zh) * 2020-10-16 2022-04-22 广东菲鹏生物有限公司 一种心肌肌钙蛋白i检测方法和试剂盒
CN114034869A (zh) * 2020-10-16 2022-02-11 广东菲鹏生物有限公司 一种心肌肌钙蛋白i检测方法和试剂盒
WO2022099314A1 (fr) * 2020-11-09 2022-05-12 Meso Scale Technologies, Llc. Procédés et kits pour détecter la protéine tau

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689777B2 (en) * 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
DE19524572A1 (de) 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
DE69724636T2 (de) 1996-06-25 2004-09-16 Hytset Ltd. Verfahren und kit zur diagnose von troponin i
WO1998029726A2 (fr) * 1996-12-27 1998-07-09 Coulter International Corp. Procede de detection de la troponine i et de determination de sa concentration totale dans un echantillon biologique
FR2779526A1 (fr) * 1998-06-09 1999-12-10 Pasteur Sanofi Diagnostics Nouveau procede de dosage de la troponine i cardiaque
US20040018577A1 (en) * 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay

Also Published As

Publication number Publication date
EP1473567B1 (fr) 2006-07-19
US20080153109A1 (en) 2008-06-26
ATE333649T1 (de) 2006-08-15
US20040219604A1 (en) 2004-11-04
ES2264079T3 (es) 2006-12-16
US7348157B2 (en) 2008-03-25
US7638292B2 (en) 2009-12-29
EP1473567A1 (fr) 2004-11-03
DE602004001533T2 (de) 2007-02-15
DE602004001533D1 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
FI20030652A0 (fi) Parannettu immunomääritys
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
ATE375516T1 (de) Immuntest zur messung des humanen c-peptides sowie reagenzienkit hierfür
EP1625163B8 (fr) Methode de detection du probnp a l'aide d'un anticorps monoclonal liant les acides amines 38 a 43
ES2129421T3 (es) Anticuerpos monoclonales que reconocen el extremo c de hbnp.
WO2007061793A3 (fr) Cardiolipine modifiee et ses utilisations
ATE459885T1 (de) Verfahren zur besserung der wiederfindung troponin i und t
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
DE69232801T2 (de) Abtrennungsverfahren
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
DE69132864D1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
EP1304336A3 (fr) Anticorps pour la détection spécifique de prions pathogènes d'origine humaine et procédés de détection les utilisants
EP2023139A4 (fr) Procédé d'immunoessai et puce
WO2004084841A3 (fr) Nouveaux anticorps d'albumine anti-feline et procedes de detection de maladies renales precoces
Ibragimova et al. Optimized immonochromatographic system for antigen determination based on monoclonal antibody conjugates with quantum dots
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
YU164090A (sh) Postopek za dokazovanje analitov
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys
DE3853282T2 (de) Diagnostischer Test für Pseudomonas Aeruginosa Infektionen.

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: ABB OY